Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
The New England Journal of Statistics in Data Science · 01.01.2026 · 192-203
DOI: 10.51387/26-nejsds107 ↗Kurz gefasst
Fachartikel in der Zeitschrift The New England Journal of Statistics in Data Science, online erschienen am 03.09.2026. Verfasst von Kyong Ju Lee und 1 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Phase I oncology trials aim to identify a safe dose—often the maximum tolerated dose (MTD)—for subsequent studies. Conventional designs focus on population-level toxicity modeling, with recent attention on leveraging pharmacokinetic (PK) data to improve dose selection. We propose the Precision Dose-Finding (PDF) design, a novel Bayesian phase I framework that integrates individual patient PK profiles into the dose-finding process. By incorporating patient-specific PK parameters (such as volume of distribution ${V_{i}}$ and elimination rate ${k_{i}}$), PDF models toxicity risk at the individual level, in contrast to traditional methods that ignore inter-patient variability. The trial is structured in two stages: an initial training stage to update model parameters using cohort-based dose escalation, and a subsequent test stage in which doses for new patients are chosen based on each patient’s own PK-predicted toxicity probability. This two-stage approach enables truly personalized dose assignment while maintaining rigorous safety oversight. Extensive simulation studies demonstrate the feasibility of PDF and suggest that it provides improved safety and dosing precision relative to the continual reassessment method (CRM). The PDF design thus offers a refined dose-finding strategy that tailors the MTD to individual patients, aligning phase I trials with the ideals of precision medicine.
Zitieren
APA
Lee, K. J., & Ji, Y. (2026). Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data. The New England Journal of Statistics in Data Science, 192-203. https://doi.org/10.51387/26-nejsds107
Vancouver
Lee KJ, Ji Y. Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data. The New England Journal of Statistics in Data Science. 2026:192-203. doi:10.51387/26-nejsds107
BibTeX
@article{Lee2026,
author = {Lee, Kyong Ju and Ji, Yuan},
title = {Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data},
journal = {The New England Journal of Statistics in Data Science},
year = {2026},
pages = {192--203},
doi = {10.51387/26-nejsds107}
}
EUVIMED